trending Market Intelligence /marketintelligence/en/news-insights/trending/ne03rouvz5gj-hmcyxlqpq2 content esgSubNav
In This List

Proteomics International Laboratories sells stake in CPR Pharma Services

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Proteomics International Laboratories sells stake in CPR Pharma Services

Proteomics International Laboratories Ltd. said it closed the sale of its stake in CPR Pharma Services Pty Ltd. for $928,399.

Perth, Australia-based Proteomics acquired a 10% stake in CPR in March for A$1.2 million. The medical technology company sold the stake as CPR Pharma Services undergoes a full takeover by an undisclosed party.

The memorandum of understanding between Proteomics and CPR Pharma Services will remain valid, covering advanced diagnostics and analytical services for clinical trials.

Adelaide, Australia-based CPR Pharma provides drug development support services to clients in the U.S. and Asia.